RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/34287648http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34287648http://www.w3.org/2000/01/rdf-schema#comment"Glioblastoma is one of the most lethal forms of adult cancer, with a median survival of ∼15 mo. Targeting glioblastoma stem-like cells (GSCs) at the origin of tumor formation and relapse may prove beneficial. In situ, GSCs are nested within the vascular bed in tight interaction with brain endothelial cells, which positively control their expansion. Because GSCs are notably addicted to apelin (APLN), sourced from the surrounding endothelial stroma, the APLN/APLNR nexus has emerged as a druggable network. However, how this signaling axis operates in gliomagenesis remains underestimated. Here, we find that the glycoprotein GP130 interacts with APLNR at the plasma membrane of GSCs and arbitrates its availability at the surface via ELMOD1, which may further impact on ARF-mediated endovesicular trafficking. From a functional standpoint, interfering with GP130 thwarts APLNR-mediated self-renewal of GSCs ex vivo. Thus, GP130 emerges as an unexpected cicerone to the G protein-coupled APLN receptor, opening new therapeutic perspectives toward the targeting of cancer stem cells."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.org/dc/terms/identifier"doi:10.1083/jcb.202004114"xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Montagnac G."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Minvielle S."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Jacobs K.A."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Bidere N."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Gavard J."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Thys A."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Andre-Gregoire G."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Trillet K."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Maghe C."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Cruard J."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/author"Diest S.G."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/name"J Cell Biol"xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/pages"e202004114"xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/title"The glycoprotein GP130 governs the surface presentation of the G protein-coupled receptor APLNR."xsd:string
http://purl.uniprot.org/citations/34287648http://purl.uniprot.org/core/volume"220"xsd:string
http://purl.uniprot.org/citations/34287648http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34287648
http://purl.uniprot.org/citations/34287648http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/34287648
http://purl.uniprot.org/uniprot/#_A0A0A0N0L2-mappedCitation-34287648http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34287648
http://purl.uniprot.org/uniprot/#_A0A0A0N0L5-mappedCitation-34287648http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34287648
http://purl.uniprot.org/uniprot/#_B2RDH3-mappedCitation-34287648http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34287648
http://purl.uniprot.org/uniprot/#_B3KUH5-mappedCitation-34287648http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34287648